Ru‐Jing Ren

2.5k total citations · 2 hit papers
54 papers, 1.5k citations indexed

About

Ru‐Jing Ren is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Ru‐Jing Ren has authored 54 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 19 papers in Molecular Biology and 13 papers in Psychiatry and Mental health. Recurrent topics in Ru‐Jing Ren's work include Alzheimer's disease research and treatments (19 papers), Dementia and Cognitive Impairment Research (11 papers) and MicroRNA in disease regulation (5 papers). Ru‐Jing Ren is often cited by papers focused on Alzheimer's disease research and treatments (19 papers), Dementia and Cognitive Impairment Research (11 papers) and MicroRNA in disease regulation (5 papers). Ru‐Jing Ren collaborates with scholars based in China, United States and Australia. Ru‐Jing Ren's co-authors include Gang Wang, Ying Wang, Wenjia Peng, Yisong Hu, Shengdi Chen, Yulei Deng, Shengdi Chen, Yongfang Zhang, Huidong Tang and Yongbo Hu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Ru‐Jing Ren

49 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sarcopenia and mild cognitive impairment among elderly adults: The first longitudinal evidence from CHARLS

2022 178 citations Ru‐Jing Ren, Ying Wang et al. profile →
Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial

2023 89 citations Xinyi Xie, Ran Tang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ru‐Jing Ren China	22	632	572	257	239	201	54	1.5k
Eloy Rodríguez‐Rodríguez Spain	27	700 1.1×	670 1.2×	149 0.6×	290 1.2×	254 1.3×	99	1.9k
Paola Piscopo Italy	22	628 1.0×	406 0.7×	275 1.1×	124 0.5×	180 0.9×	76	1.5k
Laura Ghezzi Italy	22	697 1.1×	727 1.3×	219 0.9×	171 0.7×	464 2.3×	57	1.9k
Ning Su China	23	373 0.6×	213 0.4×	258 1.0×	229 1.0×	137 0.7×	56	1.3k
Jiewen Zhang China	19	636 1.0×	466 0.8×	177 0.7×	376 1.6×	439 2.2×	87	2.0k
Gwendlyn Kollmorgen Germany	22	499 0.8×	555 1.0×	193 0.8×	397 1.7×	222 1.1×	110	1.8k
Jianzhong Bi China	23	1.0k 1.6×	379 0.7×	374 1.5×	65 0.3×	275 1.4×	68	1.8k
Wei Qin China	22	540 0.9×	540 0.9×	158 0.6×	284 1.2×	404 2.0×	89	1.8k
Xiaojie Zhang China	24	648 1.0×	235 0.4×	166 0.6×	77 0.3×	149 0.7×	88	1.5k
Paul Juneau United States	22	475 0.8×	588 1.0×	132 0.5×	87 0.4×	156 0.8×	73	2.2k

Countries citing papers authored by Ru‐Jing Ren

Since Specialization

Citations

This map shows the geographic impact of Ru‐Jing Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ru‐Jing Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ru‐Jing Ren more than expected).

Fields of papers citing papers by Ru‐Jing Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ru‐Jing Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ru‐Jing Ren. The network helps show where Ru‐Jing Ren may publish in the future.

Co-authorship network of co-authors of Ru‐Jing Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Ru‐Jing Ren. A scholar is included among the top collaborators of Ru‐Jing Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ru‐Jing Ren. Ru‐Jing Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Jiao, Jin Wang, Jin‐Tao Wang, et al.. (2025). Language dysfunction and related amyloid-β in Alzheimer’s disease mediated by brain functional connectivity changes. NeuroImage Clinical. 48. 103893–103893.

Wang, Jintao, Gang Xu, Jieli Geng, et al.. (2025). Speech digital biomarker combined with fluid biomarkers predict cognitive impairment through machine learning. Alzheimer s Research & Therapy. 17(1). 229–229.

Zhou, Wei, Hui Shen, Jintao Wang, et al.. (2024). Profiles of subgingival microbiomes and gingival crevicular metabolic signatures in patients with amnestic mild cognitive impairment and Alzheimer’s disease. Alzheimer s Research & Therapy. 16(1). 41–41. 16 indexed citations

Li, Haixia, Jintao Wang, Jianping Li, et al.. (2023). Blood biomarkers in MCI conversion to Alzheimer’s disease: a systematic review and meta-analysis. 2(2). 2 indexed citations

Zhang, Yongfang, Boyu Chen, Lina Pan, et al.. (2023). E674Q (Shanghai APP mutant), a novel amyloid precursor protein mutation, in familial late-onset Alzheimer's disease. Genes & Diseases. 11(2). 1022–1034. 7 indexed citations

Ren, Ru‐Jing. (2023). The impact of industrial policy on the stock price of the new energy vehicle industry -- Empirical analysis based on the ARIMA model. SHILAP Revista de lepidopterología. 169. 1047–1047.

Wang, Hua-Long, Ran Tang, Ru‐Jing Ren, et al.. (2022). Speech silence character as a diagnostic biomarker of early cognitive decline and its functional mechanism: a multicenter cross-sectional cohort study. BMC Medicine. 20(1). 380–380. 12 indexed citations

Huang, Qiang, Yongfang Zhang, Eric B. Dammer, et al.. (2022). Adult-Onset Neuronal Ceroid Lipofuscinosis With a Novel DNAJC5 Mutation Exhibits Aberrant Protein Palmitoylation. Frontiers in Aging Neuroscience. 14. 829573–829573. 11 indexed citations

Xie, Xinyi, Guozhen Lin, Qiang Huang, et al.. (2021). Opinions and clinical practice of functional movement disorders: a nationwide survey of clinicians in China. BMC Neurology. 21(1). 435–435. 7 indexed citations

10.

Gao, Ying, Ru‐Jing Ren, Zilin Zhong, et al.. (2019). Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer's disease. Neurobiology of Aging. 77. 154–157. 33 indexed citations

11.

Hu, Yongbo, Yongfang Zhang, Hao Wang, et al.. (2019). miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson’s disease. Cell Death and Disease. 10(8). 589–589. 92 indexed citations

12.

Zhang, Yueqi, Chunfang Wang, Gang Xu, et al.. (2019). Mortality of Alzheimer’s Disease Patients: A 10-Year Follow-up Pilot Study in Shanghai. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 47(2). 226–230. 14 indexed citations

13.

Ren, Ru‐Jing. (2017). Precision medicine of frontotemporal dementia from genotype to phenotype. Frontiers in bioscience. 23(3). 1144–1165. 5 indexed citations

14.

Zhong, Cheng, Tingting Wang, Pei Hu, et al.. (2017). Activation of dendritic cells by low molecular weight oyster polysaccharides. International Immunopharmacology. 44. 183–190. 11 indexed citations

15.

Wang, Gang, Yue Huang, Liling Wang, et al.. (2016). MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer’s disease. Scientific Reports. 6(1). 26697–26697. 97 indexed citations

16.

Xu, Wei, Jun Xu, Ying Wang, et al.. (2013). The Genetic Variation of SORCS1 Is Associated with Late-Onset Alzheimer’s Disease in Chinese Han Population. PLoS ONE. 8(5). e63621–e63621. 16 indexed citations

17.

Fang, Rong, Gang Wang, Yue Huang, et al.. (2013). Validation of the Chinese Version of Addenbrooke's Cognitive Examination-Revised for Screening Mild Alzheimer's Disease and Mild Cognitive Impairment. Dementia and Geriatric Cognitive Disorders. 37(3-4). 223–231. 39 indexed citations

18.

Wang, Gang, Xiaoling Pan, Pei‐Jing Cui, et al.. (2011). Association Study of the GAB2 Gene With the Risk of Alzheimer Disease in the Chinese Population. Alzheimer Disease & Associated Disorders. 25(3). 283–285. 12 indexed citations

19.

Wang, Gang, Jing Pan, Yuyan Tan, et al.. (2008). Neuroprotective effects of PACAP27 in mice model of Parkinson’s disease involved in the modulation of KATP subunits and D2 receptors in the striatum. Neuropeptides. 42(3). 267–276. 50 indexed citations

20.

Yang, Hongqi, Maowen Ba, Ru‐Jing Ren, et al.. (2006). Mitogen activated protein kinase and protein kinase C activation mediate promotion of sAPPα secretion by deprenyl. Neurochemistry International. 50(1). 74–82. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact